The project in a nutshell
Testing whether a protein drug called FAB4 can make the body's
own immune system attack prostate cancer cells.
Why we funded it
If successful, FAB4-guided immunotherapy could provide a new
treatment for men affected by advanced and otherwise untreatable
prostate cancer, helping to improve survival and quality of
For more detailed information on this project, please look at